Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.071 AUD | -1.39% | -4.05% | +2.90% |
04-17 | Neurotech's Phase II/III NTIASD2 Clinical Trial for Children with Autism Meets Primary Endpoint | MT |
04-17 | Neurotech International Completes AU$10 Million Capital Raise | MT |
1st Jan change | Capi. | |
---|---|---|
+2.90% | 49.17M | |
+52.36% | 56.69B | |
-3.86% | 41B | |
+38.14% | 38.11B | |
-12.01% | 26.89B | |
+14.13% | 25.59B | |
-21.62% | 18.59B | |
+0.21% | 12.39B | |
+25.96% | 11.99B | |
+23.02% | 11.88B |
- Stock Market
- Equities
- NTI Stock
- News Neurotech International Limited
- Neurotech International Limited Announces Transition of Peter Griffiths as CEO